Although local hospitals claimed there was overcapacity for cancer treatment in the area, the department said there were enough cancer patients for all hospitals, including Memorial Sloan-Kettering. The department’s approval was based on projections of population growth and an increase in the incidence of cancer in Westchester, primarily due to an aging population.
Related Articles on Memorial Sloan-Kettering Cancer Center:
Hospitals in New York City Suburbs Oppose Memorial Sloan-Kettering’s Plan for New Cancer Center
Northern Metropolitan Hospital Association Opposes Cancer Center
Memorial Sloan-Kettering Cancer Center Stops Tap Water Use After Water Supply Test Showed Traces of Legionella
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit